Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cottrell, D. A.
Right arrow Articles by Ebers, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cottrell, D. A.
Right arrow Articles by Ebers, G. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 122, No. 4, 641-647, April 1999
© 1999 Oxford University Press

The natural history of multiple sclerosis: a geographically based study

6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis

D. A. Cottrell, M. Kremenchutzky, G. P. A. Rice, W. Hader, J. Baskerville and G. C. Ebers

Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada

Correspondence to: Dr G. C. Ebers, Department of Clinical Neurological Sciences, London Health Sciences Centre-University Campus, London, Ontario, Canada N6A 5A5 E-mail: gebers{at}lhsc.on.ca

The natural history of primary progressive multiple sclerosis (PP-multiple sclerosis) recently has been defined in a geographically based multiple sclerosis population. For a series of prognostically defined hypothetical entry criteria based upon current trends in presentation to the London Multiple Sclerosis Clinic, we determined the number of patients who would have been trial eligible. Using 23 year mean longitudinal natural history data, we identified the observed rate of deterioration for frequently used trial endpoints. Hypothetical entry criteria were based on the practical considerations which would attend the execution of clinical trials in progressive multiple sclerosis. We then developed a series of sample size tables giving the number of patients with PP-multiple sclerosis and the length of observation that would be required to detect a significant result (P = 0.05) for a 25, 50 and 75% decrease in the median time to progression with 80 or 90% power, with treatment efficacy based upon the ability to slow progression on the disability status score. It is expected that the considerations outlined here will prove useful for both trial design and interpretation of trials in PP-multiple sclerosis which will require multi-centre collaborative efforts.

primary progressive-multiple sclerosis; natural history; progression rate; treatment; clinical trials

DSS = disability status score; EDSS = extended disability status score; PP-multiple sclerosis = primary progressive multiple sclerosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
L. Bosma, J. Kragt, L Brieva, Z Khaleeli, X Montalban, C. Polman, A. Thompson, M Tintore, and B. Uitdehaag
The search for responsive clinical endpoints in primary progressive multiple sclerosis
Multiple Sclerosis, June 1, 2009; 15(6): 715 - 720.
[Abstract] [PDF]


Home page
Mult SclerHome page
H Butzkueven, J Chapman, E Cristiano, F Grand'Maison, M Hoffmann, G Izquierdo, D Jolley, L Kappos, T Leist, D Pohlau, et al.
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis
Multiple Sclerosis, November 1, 2006; 12(6): 769 - 774.
[Abstract] [PDF]


Home page
BrainHome page
M. Kremenchutzky, G. P. A. Rice, J. Baskerville, D. M. Wingerchuk, and G. C. Ebers
The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease
Brain, March 1, 2006; 129(3): 584 - 594.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S L Minden, D Frankel, L Hadden, J Perloff, K P Srinath, and D C Hoaglin
The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics
Multiple Sclerosis, February 1, 2006; 12(1): 24 - 38.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Oh, R G Henry, C Genain, S J Nelson, and D Pelletier
Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging
J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1281 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
G. C Ebers
Natural history of primary progressive multiple sclerosis
Multiple Sclerosis, June 1, 2004; 10(1_suppl): S8 - S15.
[Abstract] [PDF]


Home page
Mult SclerHome page
G. C Ebers
Natural history of primary progressive multiple sclerosis
Multiple Sclerosis, May 1, 2004; 10(3_suppl): S8 - S15.
[Abstract] [PDF]


Home page
BrainHome page
G. T. Ingle, V. L. Stevenson, D. H. Miller, and A. J. Thompson
Primary progressive multiple sclerosis: a 5-year clinical and MR study
Brain, November 1, 2003; 126(11): 2528 - 2536.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
G T Ingle, V L Stevenson, D H Miller, S M Leary, M Rovaris, F Barkhof, B Brochet, V Dousset, M Filippi, X Montalban, et al.
Two-year follow-up study of primary and transitional progressive multiple sclerosis
Multiple Sclerosis, April 1, 2002; 8(2): 108 - 114.
[Abstract] [PDF]


Home page
Mult SclerHome page
X Montalban and A J Thompson
Workshop on primary progressive multiple sclerosis: meeting summary
Multiple Sclerosis, April 1, 2002; 8(2): 177 - 178.
[PDF]


Home page
NEJMHome page
J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker
Multiple Sclerosis
N. Engl. J. Med., September 28, 2000; 343(13): 938 - 952.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
V L Stevenson, D H Miller, S M Leary, M Rovaris, F Barkhof, B Brochet, V Dousset, V Dousset, M Filippi, R Hintzen, et al.
One year follow up study of primary and transitional progressive multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 713 - 718.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Kremenchutzky, D Lee, G P A Rice, and G C Ebers
Diagnostic brain MRI findings in primary progressive multiple sclerosis
Multiple Sclerosis, April 1, 2000; 6(2): 81 - 85.
[Abstract] [PDF]


Home page
BrainHome page
G. C. Ebers, W. J. Koopman, W. Hader, A. D. Sadovnick, M. Kremenchutzky, P. Mandalfino, D. M. Wingerchuk, J. Baskerville, and G. P. A. Rice
The natural history of multiple sclerosis: a geographically based study: 8: Familial multiple sclerosis
Brain, March 1, 2000; 123(3): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Kremenchutzky, D. Cottrell, G. Rice, W. Hader, J. Baskerville, W. Koopman, and G. C. Ebers
The natural history of multiple sclerosis: a geographically based study: 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation
Brain, October 1, 1999; 122(10): 1941 - 1950.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. Rudge
The value of natural history studies of multiple sclerosis
Brain, April 1, 1999; 122(4): 591 - 592.
[Full Text] [PDF]


Home page
BrainHome page
D. A. Cottrell, M. Kremenchutzky, G. P. A. Rice, W. J. Koopman, W. Hader, J. Baskerville, and G. C. Ebers
The natural history of multiple sclerosis:a geographically based study: 5. The clinical features and natural history of primary progressive multiple sclerosis
Brain, April 1, 1999; 122(4): 625 - 639.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.